Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6105-6121
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6105
Figure 1
Figure 1 Immunization approaches against coronavirus disease 2019. COVID: Coronavirus disease 2019.
Figure 2
Figure 2  Assignment of the included coronavirus-infected cases at their groups.
Figure 3
Figure 3  Frequency of interventions in included patients.
Figure 4
Figure 4 Flow chart of patients in the study. A = casirivimab/imdevimab; B = remdesivir; C = favipiravir.